Birdwatch Note
2024-11-09 13:35:44 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
下記の研究について触れています。 https://ijirms.in/index.php/ijirms/article/view/1982 この話はインフルワクチン等と比較したコロナワクチンのVAERSと呼ばれる任意の因果関係を賭wな愛有害事象報告数の報告率の事ですが(上記リンク こうした任意の報告は報道や https://www.sciencedirect.com/science/article/pii/S1054139X13004874 販売後の時間等 https://www.mdpi.com/2076-393X/8/1/117 多様な影響を受けCDCは因果関係推定には使えないとVAERSの説明項目で明示しています https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html#:~:text=VAERS%20is%20the%20nation's%20early,make%20sure%20vaccines%20are%20safe. 例えばわが国の副反応疑い報告でも同じコロナワクチンでも最初の4ロットと比べると22年の最初の4ロットでは全副反応疑い報告率は約百分の1です(下記74P https://www.mhlw.go.jp/content/10601000/00109164.pdf
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1855192572748292231
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1855242874423763250
- noteId - 1855242874423763250
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1731159344665
- tweetId - 1855192572748292231
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 0
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 下記の研究について触れています。 https://ijirms.in/index.php/ijirms/article/view/1982 この話はインフルワクチン等と比較したコロナワクチンのVAERSと呼ばれる任意の因果関係を賭wな愛有害事象報告数の報告率の事ですが(上記リンク こうした任意の報告は報道や https://www.sciencedirect.com/science/article/pii/S1054139X13004874 販売後の時間等 https://www.mdpi.com/2076-393X/8/1/117 多様な影響を受けCDCは因果関係推定には使えないとVAERSの説明項目で明示しています https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html#:~:text=VAERS%20is%20the%20nation's%20early,make%20sure%20vaccines%20are%20safe. 例えばわが国の副反応疑い報告でも同じコロナワクチンでも最初の4ロットと比べると22年の最初の4ロットでは全副反応疑い報告率は約百分の1です(下記74P https://www.mhlw.go.jp/content/10601000/00109164.pdf
Note Ratings
| rated at | rated by | |
| 2024-11-10 18:54:26 -0600 | Rating Details | |
| 2024-11-10 17:18:51 -0600 | Rating Details | |
| 2024-11-10 09:41:12 -0600 | Rating Details | |
| 2024-11-10 05:57:43 -0600 | Rating Details | |
| 2024-11-10 05:51:45 -0600 | Rating Details | |
| 2024-11-10 05:25:40 -0600 | Rating Details | |
| 2024-11-10 04:33:14 -0600 | Rating Details | |
| 2024-11-10 04:27:30 -0600 | Rating Details | |
| 2024-11-10 04:22:21 -0600 | Rating Details | |
| 2024-11-10 02:44:28 -0600 | Rating Details | |
| 2024-11-09 21:13:22 -0600 | Rating Details | |
| 2024-11-09 20:26:30 -0600 | Rating Details | |
| 2024-11-09 20:26:07 -0600 | Rating Details | |
| 2024-11-09 20:00:34 -0600 | Rating Details | |
| 2024-11-09 19:53:59 -0600 | Rating Details | |
| 2024-11-09 19:12:25 -0600 | Rating Details | |
| 2024-11-09 19:01:27 -0600 | Rating Details | |
| 2024-11-09 18:02:01 -0600 | Rating Details | |
| 2024-11-09 17:51:36 -0600 | Rating Details | |
| 2024-11-09 17:49:59 -0600 | Rating Details | |
| 2024-11-09 17:41:22 -0600 | Rating Details | |
| 2024-11-09 17:38:43 -0600 | Rating Details | |
| 2024-11-09 17:17:14 -0600 | Rating Details | |
| 2024-11-09 16:52:29 -0600 | Rating Details | |
| 2024-11-09 16:30:51 -0600 | Rating Details | |
| 2024-11-09 14:56:50 -0600 | Rating Details | |
| 2024-11-09 14:37:14 -0600 | Rating Details | |
| 2024-11-09 14:34:35 -0600 | Rating Details | |
| 2024-11-09 14:32:35 -0600 | Rating Details | |
| 2024-11-09 14:30:36 -0600 | Rating Details | |
| 2024-11-09 14:10:36 -0600 | Rating Details | |
| 2024-11-09 14:06:06 -0600 | Rating Details | |
| 2024-11-09 13:57:45 -0600 | Rating Details | |
| 2024-11-09 12:50:30 -0600 | Rating Details | |
| 2024-11-09 11:43:28 -0600 | Rating Details | |
| 2024-11-09 11:35:34 -0600 | Rating Details | |
| 2024-11-09 11:32:00 -0600 | Rating Details | |
| 2024-11-09 11:15:06 -0600 | Rating Details | |
| 2024-11-09 11:13:09 -0600 | Rating Details | |
| 2024-11-09 10:48:51 -0600 | Rating Details | |
| 2024-11-09 10:19:32 -0600 | Rating Details | |
| 2024-11-09 10:07:34 -0600 | Rating Details | |
| 2024-11-09 09:13:36 -0600 | Rating Details | |
| 2024-11-09 08:40:32 -0600 | Rating Details | |
| 2024-11-09 08:34:24 -0600 | Rating Details | |
| 2024-11-09 08:17:32 -0600 | Rating Details | |
| 2024-11-09 08:07:20 -0600 | Rating Details | |
| 2024-11-09 07:38:19 -0600 | Rating Details | |
| 2024-11-10 23:01:38 -0600 | Rating Details | |
| 2024-11-10 20:43:13 -0600 | Rating Details | |
| 2024-11-10 13:32:10 -0600 | Rating Details | |
| 2024-11-10 08:05:24 -0600 | Rating Details | |
| 2024-11-10 03:50:31 -0600 | Rating Details | |
| 2024-11-10 01:35:20 -0600 | Rating Details | |
| 2024-11-10 00:55:39 -0600 | Rating Details | |
| 2024-11-09 20:34:25 -0600 | Rating Details | |
| 2024-11-09 19:30:22 -0600 | Rating Details | |
| 2024-11-09 19:15:21 -0600 | Rating Details | |
| 2024-11-09 18:17:40 -0600 | Rating Details | |
| 2024-11-09 16:53:36 -0600 | Rating Details | |
| 2024-11-09 14:19:36 -0600 | Rating Details | |
| 2024-11-09 13:50:06 -0600 | Rating Details | |
| 2024-11-09 13:14:54 -0600 | Rating Details | |
| 2024-11-09 11:03:32 -0600 | Rating Details | |
| 2024-11-09 09:57:38 -0600 | Rating Details | |
| 2024-11-09 09:44:23 -0600 | Rating Details | |
| 2024-11-09 09:20:18 -0600 | Rating Details | |
| 2024-11-09 09:01:48 -0600 | Rating Details | |
| 2024-11-09 08:31:33 -0600 | Rating Details | |
| 2024-11-11 09:58:44 -0600 | Rating Details | |
| 2024-11-11 07:24:49 -0600 | Rating Details |